n-3 polyunsaturated fatty acid supplementation during cancer chemotherapy

Article English OPEN
Morland, Sarah Louise; Martins, Karen J.B.; Mazurak, Vera C.;
  • Publisher: Elsevier BV
  • Journal: Journal of Nutrition & Intermediary Metabolism,volume 5,pages107-116 (issn: 2352-3859)
  • Publisher copyright policies & self-archiving
  • Related identifiers: doi: 10.1016/j.jnim.2016.05.001
  • Subject: Clinical trial | Nutrition. Foods and food supply | Eicosapentaenoic acid | TX341-641 | QD415-436 | Fish oil | Biochemistry | Docosohexaenoic acid | Cancer | Oncology

Evidence from several clinical trials suggests that n-3 polyunsaturated fatty acid (n-3 PUFA) supplementation during cancer chemotherapy improves patient outcomes related to chemotherapy tolerability, regardless of the type of chemotherapy used. While the effects of n-3... View more
Share - Bookmark